Gradient Capital Advisors, LLC Amgen Inc Transaction History

Gradient Capital Advisors, LLC

$296 Million
Q3 2024

A detailed history of Gradient Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Gradient Capital Advisors, LLC holds 3,577 shares of AMGN stock, worth $997,124. This represents 0.39% of its overall portfolio holdings.

Number of Shares

3,577

Previous 3,569 0.22%

Holding current value

$997,124

Previous $1.12 Million 3.32%

% of portfolio

0.39%

Previous 0.4%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$309.38 - $337.38 $2,475 - $2,699	8 Added 0.22%	3,577 $1.15 Million
Q2 2024 Jul 19, 2024	BUY	$262.75 - $319.31 $2,364 - $2,873	9 Added 0.25%	3,569 $1.12 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $2,688 - $3,245	-10 Reduced 0.28%	3,560 $1.01 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $3,324 - $3,749	-13 Reduced 0.36%	3,570 $1.03 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $19,022 - $23,617	87 Added 2.49%	3,583 $962,000
Q2 2023 Jul 18, 2023	SELL	$214.27 - $253.37 $10,499 - $12,415	-49 Reduced 1.38%	3,496 $776,000
Q1 2023 Apr 17, 2023	SELL	$225.79 - $275.2 $10,160 - $12,384	-45 Reduced 1.25%	3,545 $857,000
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $3,893 - $4,947	17 Added 0.48%	3,590 $942,000
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $127,493 - $143,789	568 Added 18.9%	3,573 $805,000
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $443,655 - $493,711	1,923 Added 177.73%	3,005 $731,000
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $18,199 - $20,133	-83 Reduced 7.12%	1,082 $262,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $994 - $1,138	5 Added 0.43%	1,165 $262,000
Q3 2021 Nov 02, 2021	SELL	$212.27 - $248.7 $2,547 - $2,984	-12 Reduced 1.02%	1,160 $247,000
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $5,372 - $5,960	23 Added 2.0%	1,172 $286,000
Q1 2021 Apr 21, 2021	BUY	$221.91 - $258.6 $1,331 - $1,551	6 Added 0.52%	1,149 $286,000
Q4 2020 Jan 20, 2021	BUY	$216.38 - $257.67 $14,281 - $17,006	66 Added 6.13%	1,143 $263,000
Q3 2020 Oct 21, 2020	SELL	$234.65 - $260.95 $19,006 - $21,136	-81 Reduced 6.99%	1,077 $274,000
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $229,063 - $281,092	1,158 New	1,158 $273,000
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $172,399 - $228,648	-946 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$189.21 - $243.2 $178,992 - $230,067	946 New	946 $228,000

Others Institutions Holding AMGN

# of Institutions

3,120

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Capital Advisors, LLC with notifications on news.

Account

Gradient Capital Advisors, LLC Amgen Inc Transaction History